Joao da Rocha Fernandes1, Katherine Ogurtsova2, Ute Linnenkamp3, Leonor Guariguata4, Till Seuring5, Ping Zhang6, David Cavan7, Lydia E Makaroff8. 1. International Diabetes Federation, Brussels, Belgium. Electronic address: joao.fernandes@idf.org. 2. International Diabetes Federation, Brussels, Belgium. Electronic address: katherine.ogurtsova@idf.org. 3. International Diabetes Federation, Brussels, Belgium. Electronic address: ute_linnenkamp@gmx.de. 4. International Diabetes Federation, Brussels, Belgium. Electronic address: leonor.guariguata@gmail.com. 5. International Diabetes Federation, Brussels, Belgium. Electronic address: till.seuring@gmail.com. 6. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: paz2@cdc.gov. 7. International Diabetes Federation, Brussels, Belgium. Electronic address: david.cavan@idf.org. 8. International Diabetes Federation, Brussels, Belgium. Electronic address: lydia.makaroff@idf.org.
Abstract
AIMS: To estimate health expenditures due to diabetes in 2014 for the world and its regions. METHODS: Diabetes-attributable health expenditures were estimated using an attributable fraction method. Data were sourced from International Diabetes Federation (IDF) estimates of diabetes prevalence, UN population projections, WHO annual health expenditure reports, and estimates of the cost ratio of people with and without diabetes. Health expenditures were calculated in both US dollars (USD) and international dollars (ID). RESULTS: The average health expenditure per person with diabetes worldwide in 2014 was estimated to range from USD 1583 (ID 1742) to USD 2842 (ID 3110). The estimated annual global health expenditure attributable to diabetes ranged from USD 612 billion (ID 673 billion) to USD 1099 billion (ID 1202 billion). Together, the North America and Caribbean Region and the Europe Region were responsible for over 69% of the costs, and less than 10% of the costs were from the Africa Region, South East Asia Region, and Middle East and North Africa Region combined. The North America and Caribbean Region had the highest annual spending per person with diabetes (USD 7984 [ID 8040.39]), while the South East Asia Region had the lowest annual spending per person with diabetes (USD 92 [ID 234]). CONCLUSIONS: Diabetes imposes a large economic burden on health care systems across the world, yet varies across world regions. Diabetes prevention and effective management of diabetes should be a public health priority to reduce the financial burden.
AIMS: To estimate health expenditures due to diabetes in 2014 for the world and its regions. METHODS:Diabetes-attributable health expenditures were estimated using an attributable fraction method. Data were sourced from International Diabetes Federation (IDF) estimates of diabetes prevalence, UN population projections, WHO annual health expenditure reports, and estimates of the cost ratio of people with and without diabetes. Health expenditures were calculated in both US dollars (USD) and international dollars (ID). RESULTS: The average health expenditure per person with diabetes worldwide in 2014 was estimated to range from USD 1583 (ID 1742) to USD 2842 (ID 3110). The estimated annual global health expenditure attributable to diabetes ranged from USD 612 billion (ID 673 billion) to USD 1099 billion (ID 1202 billion). Together, the North America and Caribbean Region and the Europe Region were responsible for over 69% of the costs, and less than 10% of the costs were from the Africa Region, South East Asia Region, and Middle East and North Africa Region combined. The North America and Caribbean Region had the highest annual spending per person with diabetes (USD 7984 [ID 8040.39]), while the South East Asia Region had the lowest annual spending per person with diabetes (USD 92 [ID 234]). CONCLUSIONS:Diabetes imposes a large economic burden on health care systems across the world, yet varies across world regions. Diabetes prevention and effective management of diabetes should be a public health priority to reduce the financial burden.
Authors: Daniel M Rotroff; Sook Wah Yee; Kaixin Zhou; Skylar W Marvel; Hetal S Shah; John R Jack; Tammy M Havener; Monique M Hedderson; Michiaki Kubo; Mark A Herman; He Gao; Josyf C Mychaleckyi; Howard L McLeod; Alessandro Doria; Kathleen M Giacomini; Ewan R Pearson; Michael J Wagner; John B Buse; Alison A Motsinger-Reif Journal: Diabetes Date: 2018-04-12 Impact factor: 9.461